{"transactions":[{"id":814478,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":53594,"kind":"person","name":"Bellon Christine","position":1,"cik":"0001963878","reported_name":"Bellon Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-04-06T21:39:44.000Z","date":"2026-04-01","kind":"sale","planned":true,"acquired":false,"shares":5956,"price":24.58,"value":146398.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares of common stock were automatically sold in a non-discretionary transaction by the Reporting Person in order to cover tax withholding obligations upon the vesting of certain restricted stock units granted to the Reporting Person under the Beam Therapeutics Inc. 2019 Equity Incentive Plan on each of March 31, 2022, March 31, 2023, March 31, 2024 and March 31, 2025. The sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 19, 2023."}],"balance_after":109711,"source":{"system":"sec-edgar","filing":"0001193125-26-144067","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000119312526144067/ownership.xml","form_type":"4"}},{"id":819694,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":53594,"kind":"person","name":"Bellon Christine","position":1,"cik":"0001963878","reported_name":"Bellon Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-04-02T21:27:06.000Z","date":"2026-03-31","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted to the Reporting Person under the Beam Therapeutics Inc. (\"BEAM\") 2019 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of BEAM's common stock. The RSUs vest in four substantially equal installments on each of the first four anniversaries of the date of grant, subject to the Reporting Person's continued service with BEAM through each vesting date."}],"balance_after":115667,"source":{"system":"sec-edgar","filing":"0001193125-26-140586","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000119312526140586/ownership.xml","form_type":"4"}},{"id":925229,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":53594,"kind":"person","name":"Bellon Christine","position":1,"cik":"0001963878","reported_name":"Bellon Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-02T21:05:09.000Z","date":"2026-01-31","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option vests in equal monthly installments each month following the date of grant for the subsequent 48 months, subject to the Reporting Person's continued service with Beam Therapeutics Inc. through each vesting date."}],"balance_after":40000,"derivative":{"exercise_price":27.62,"expiration_date":"2036-01-31","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001193125-26-033601","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000119312526033601/ownership.xml","form_type":"4"}},{"id":931195,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":53594,"kind":"person","name":"Bellon Christine","position":1,"cik":"0001963878","reported_name":"Bellon Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-01-26T21:05:02.000Z","date":"2026-01-22","kind":"sale","planned":true,"acquired":false,"shares":1371,"price":34,"value":46614.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 16, 2025."}],"balance_after":95667,"source":{"system":"sec-edgar","filing":"0001193125-26-022557","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000119312526022557/ownership.xml","form_type":"4"}},{"id":935428,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":53594,"kind":"person","name":"Bellon Christine","position":1,"cik":"0001963878","reported_name":"Bellon Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-01-20T21:05:03.000Z","date":"2026-01-15","kind":"sale","planned":true,"acquired":false,"shares":559,"price":35.3988,"value":19787.9292,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 16, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $35.38 to $35.485, inclusive. The Reporting Person undertakes to provide to BEAM, any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":97038,"source":{"system":"sec-edgar","filing":"0001193125-26-016552","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000119312526016552/ownership.xml","form_type":"4"}},{"id":935427,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":53594,"kind":"person","name":"Bellon Christine","position":1,"cik":"0001963878","reported_name":"Bellon Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-01-20T21:05:03.000Z","date":"2026-01-15","kind":"sale","planned":true,"acquired":false,"shares":15959,"price":34.7182,"value":554067.7538,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 16, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $34.355 to $35.34, inclusive. The Reporting Person undertakes to provide to BEAM, any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":97597,"source":{"system":"sec-edgar","filing":"0001193125-26-016552","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000119312526016552/ownership.xml","form_type":"4"}},{"id":935426,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":53594,"kind":"person","name":"Bellon Christine","position":1,"cik":"0001963878","reported_name":"Bellon Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-01-20T21:05:03.000Z","date":"2026-01-15","kind":"sale","planned":true,"acquired":false,"shares":2111,"price":33.6219,"value":70975.8309,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 16, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $33.17 to $34.15, inclusive. The Reporting Person undertakes to provide to Beam Therapeutics Inc. (\"BEAM\"), any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":113556,"source":{"system":"sec-edgar","filing":"0001193125-26-016552","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000119312526016552/ownership.xml","form_type":"4"}},{"id":951669,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":53594,"kind":"person","name":"Bellon Christine","position":1,"cik":"0001963878","reported_name":"Bellon Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-01-05T21:12:50.000Z","date":"2025-12-31","kind":"sale","planned":true,"acquired":false,"shares":1254,"price":27.1,"value":33983.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares of common stock were automatically sold in a non-discretionary transaction by the Reporting Person in order to cover tax withholding obligations upon the vesting of certain restricted stock units granted to the Reporting Person under the Beam Therapeutics Inc. (\"BEAM\") 2019 Equity Incentive Plan on December 30, 2022. The sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 19, 2023."}],"balance_after":115667,"source":{"system":"sec-edgar","filing":"0001193125-26-002427","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000119312526002427/ownership.xml","form_type":"4"}},{"id":1024649,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":53594,"kind":"person","name":"Bellon Christine","position":1,"cik":"0001963878","reported_name":"Bellon Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-10-03T20:10:15.000Z","date":"2025-10-01","kind":"sale","planned":true,"acquired":false,"shares":373,"price":24.53,"value":9149.69,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares of common stock were automatically sold in a non-discretionary transaction by the Reporting Person in order to cover tax withholding obligations upon the vesting of certain restricted stock units granted to the Reporting Person under the Beam Therapeutics Inc. 2019 Equity Incentive Plan on September 30, 2021. The sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 19, 2023."}],"balance_after":116921,"source":{"system":"sec-edgar","filing":"0001193125-25-230148","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000119312525230148/ownership.xml","form_type":"4"}},{"id":1179737,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":53594,"kind":"person","name":"Bellon Christine","position":1,"cik":"0001963878","reported_name":"Bellon Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-04-04T01:53:04.000Z","date":"2025-04-01","kind":"sale","planned":true,"acquired":false,"shares":5674,"price":18.3507,"value":104121.8718,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"shares of common stock were automatically sold in a non-discretionary transaction by the Reporting Person in order to cover tax withholding obligations upon the vesting of certain restricted stock units granted to the Reporting Person under the Beam Therapeutics Inc. (\"BEAM\") 2019 Equity Incentive Plan on each of March 31, 2021, March 31, 2022, March 31, 2023 and March 31, 2024. The sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 19, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $17.76 to $18.38, inclusive. The Reporting Person undertakes to provide to BEAM, any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":117294,"source":{"system":"sec-edgar","filing":"0000950170-25-050859","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000095017025050859/ownership.xml","form_type":"4"}},{"id":1183622,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":53594,"kind":"person","name":"Bellon Christine","position":1,"cik":"0001963878","reported_name":"Bellon Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-04-02T23:21:37.000Z","date":"2025-03-31","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted to the Reporting Person under the Beam Therapeutics Inc. (\"BEAM\") 2019 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of BEAM's common stock. The RSUs vest in four substantially equal installments on each of the first four anniversaries of the date of grant, subject to the Reporting Person's continued service with BEAM through each vesting date."}],"balance_after":122968,"source":{"system":"sec-edgar","filing":"0000950170-25-049769","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000095017025049769/ownership.xml","form_type":"4"}},{"id":1260141,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":53594,"kind":"person","name":"Bellon Christine","position":1,"cik":"0001963878","reported_name":"Bellon Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-19T21:10:06.000Z","date":"2025-02-14","kind":"exercise","planned":true,"acquired":false,"shares":508,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vested as to 25% on the first anniversary of the vesting commencement date, May 17, 2020, and at a rate of 2.78% each month thereafter until the option was fully vested."}],"balance_after":10410,"derivative":{"exercise_price":7.22,"expiration_date":"2029-05-17","underlying":"Common Stock","underlying_shares":508},"source":{"system":"sec-edgar","filing":"0000950170-25-023166","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000095017025023166/ownership.xml","form_type":"4"}},{"id":1260140,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":53594,"kind":"person","name":"Bellon Christine","position":1,"cik":"0001963878","reported_name":"Bellon Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-19T21:10:06.000Z","date":"2025-02-14","kind":"exercise","planned":true,"acquired":false,"shares":9492,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vested as to 25% on the first anniversary of the vesting commencement date, May 16, 2020, and at a rate of 2.78% each month thereafter until the option was fully vested."}],"balance_after":0,"derivative":{"exercise_price":7.22,"expiration_date":"2029-05-16","underlying":"Common Stock","underlying_shares":9492},"source":{"system":"sec-edgar","filing":"0000950170-25-023166","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000095017025023166/ownership.xml","form_type":"4"}},{"id":1260139,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":53594,"kind":"person","name":"Bellon Christine","position":1,"cik":"0001963878","reported_name":"Bellon Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-02-19T21:10:06.000Z","date":"2025-02-14","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":34,"value":340000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 20, 2024."}],"balance_after":102968,"source":{"system":"sec-edgar","filing":"0000950170-25-023166","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000095017025023166/ownership.xml","form_type":"4"}},{"id":1260138,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":53594,"kind":"person","name":"Bellon Christine","position":1,"cik":"0001963878","reported_name":"Bellon Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-02-19T21:10:06.000Z","date":"2025-02-14","kind":"exercise","planned":true,"acquired":true,"shares":508,"price":7.22,"value":3667.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 20, 2024."}],"balance_after":112968,"source":{"system":"sec-edgar","filing":"0000950170-25-023166","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000095017025023166/ownership.xml","form_type":"4"}},{"id":1260137,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":53594,"kind":"person","name":"Bellon Christine","position":1,"cik":"0001963878","reported_name":"Bellon Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-02-19T21:10:06.000Z","date":"2025-02-14","kind":"exercise","planned":true,"acquired":true,"shares":9492,"price":7.22,"value":68532.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 20, 2024."}],"balance_after":112460,"source":{"system":"sec-edgar","filing":"0000950170-25-023166","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000095017025023166/ownership.xml","form_type":"4"}},{"id":1287497,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":53594,"kind":"person","name":"Bellon Christine","position":1,"cik":"0001963878","reported_name":"Bellon Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-03T21:05:11.000Z","date":"2025-01-31","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option vests in equal monthly installments each month following the date of grant for the subsequent 48 months, subject to the Reporting Person's continued service with BEAM through each vesting date."}],"balance_after":40000,"derivative":{"exercise_price":25.92,"expiration_date":"2035-01-31","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0000950170-25-012307","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000095017025012307/ownership.xml","form_type":"4"}},{"id":1310822,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":53594,"kind":"person","name":"Bellon Christine","position":1,"cik":"0001963878","reported_name":"Bellon Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-01-06T22:49:34.000Z","date":"2025-01-02","kind":"sale","planned":true,"acquired":false,"shares":1241,"price":24.68,"value":30627.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares of common stock were automatically sold in a non-discretionary transaction by the Reporting Person in order to cover tax withholding obligations upon the vesting of certain restricted stock units granted to the Reporting Person under the Beam Therapeutics Inc. (\"BEAM\") 2019 Equity Incentive Plan on December 30, 2022. The sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 19, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $24.21 to $25.02, inclusive. The Reporting Person undertakes to provide to BEAM, any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":102968,"source":{"system":"sec-edgar","filing":"0000950170-25-002358","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000095017025002358/ownership.xml","form_type":"4"}},{"id":1394573,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":53594,"kind":"person","name":"Bellon Christine","position":1,"cik":"0001963878","reported_name":"Bellon Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2024-10-02T21:52:20.000Z","date":"2024-10-01","kind":"sale","planned":true,"acquired":false,"shares":385,"price":23.4794,"value":9039.569,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares of common stock were automatically sold in a non-discretionary transaction by the Reporting Person in order to cover tax withholding obligations upon the vesting of certain restricted stock units granted to the Reporting Person under the Beam Therapeutics Inc. (\"BEAM\") 2019 Equity Incentive Plan on September 30, 2021. The sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 19, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $23.46 to $23.48, inclusive. The Reporting Person undertakes to provide to BEAM, any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":104209,"source":{"system":"sec-edgar","filing":"0000950170-24-111739","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000095017024111739/ownership.xml","form_type":"4"}},{"id":1549852,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":53594,"kind":"person","name":"Bellon Christine","position":1,"cik":"0001963878","reported_name":"Bellon Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2024-04-03T23:40:21.000Z","date":"2024-04-01","kind":"sale","planned":true,"acquired":false,"shares":3401,"price":32.12,"value":109240.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares of common stock were automatically sold in a non-discretionary transaction by the Reporting Person in order to cover tax withholding obligations upon the vesting of certain restricted stock units granted to the Reporting Person under the Beam Therapeutics Inc. (\"BEAM\") 2019 Equity Incentive Plan on each of March 31, 2021, March 31, 2022 and March 31, 2023. The sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 19, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $32.09 to $32.18, inclusive. The Reporting Person undertakes to provide to BEAM, any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":104594,"source":{"system":"sec-edgar","filing":"0000950170-24-041438","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000095017024041438/ownership.xml","form_type":"4"}},{"id":1553722,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":53594,"kind":"person","name":"Bellon Christine","position":1,"cik":"0001963878","reported_name":"Bellon Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2024-04-02T20:10:08.000Z","date":"2024-03-31","kind":"grant","planned":false,"acquired":true,"shares":27500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted to the Reporting Person under the Beam Therapeutics Inc. (\"BEAM\") 2019 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of BEAM's common stock. The RSUs vest in four substantially equal installments on each of the first four anniversaries of the date of grant, subject to the Reporting Person's continued service with BEAM through each vesting date."}],"balance_after":107995,"source":{"system":"sec-edgar","filing":"0000950170-24-040150","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000095017024040150/ownership.xml","form_type":"4"}},{"id":1661854,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":53594,"kind":"person","name":"Bellon Christine","position":1,"cik":"0001963878","reported_name":"Bellon Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-02T21:05:25.000Z","date":"2024-01-31","kind":"grant","planned":false,"acquired":true,"shares":55000,"price":24.4,"value":1342000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option vests in equal monthly installments each month following the date of grant for the subsequent 48 months, subject to the Reporting Person's continued service with Beam Therapeutics Inc. through each vesting date"}],"balance_after":55000,"derivative":{"exercise_price":24.4,"expiration_date":"2034-01-31","underlying":"Common Stock","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0000950170-24-010479","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000095017024010479/ownership.xml","form_type":"4"}},{"id":1685569,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":53594,"kind":"person","name":"Bellon Christine","position":1,"cik":"0001963878","reported_name":"Bellon Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2024-01-05T21:30:09.000Z","date":"2024-01-03","kind":"sale","planned":true,"acquired":false,"shares":1907,"price":26.42,"value":50382.94,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares of common stock were automatically sold in a non-discretionary transaction by the Reporting Person in order to cover tax withholding obligations upon the vesting of certain restricted stock units granted to the Reporting Person under the Beam Therapeutics Inc. 2019 Equity Incentive Plan on December 30, 2022.  The sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 19, 2023."}],"balance_after":80495,"source":{"system":"sec-edgar","filing":"0000950170-24-002480","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000095017024002480/ownership.xml","form_type":"4"}},{"id":1731343,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":53594,"kind":"person","name":"Bellon Christine","position":1,"cik":"0001963878","reported_name":"Bellon Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-11-22T21:05:11.000Z","date":"2023-11-20","kind":"exercise","planned":true,"acquired":false,"shares":5818,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests as to 25% on the first anniversary of the vesting commencement date, May 17, 2020, and at a rate of 2.78% each month thereafter until the option is fully vested."}],"balance_after":10918,"derivative":{"exercise_price":7.22,"expiration_date":"2029-05-17","underlying":"Common Stock","underlying_shares":5818},"source":{"system":"sec-edgar","filing":"0000950170-23-065868","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000095017023065868/ownership.xml","form_type":"4"}},{"id":1731342,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":53594,"kind":"person","name":"Bellon Christine","position":1,"cik":"0001963878","reported_name":"Bellon Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-11-22T21:05:11.000Z","date":"2023-11-20","kind":"exercise","planned":true,"acquired":false,"shares":4182,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests as to 25% on the first anniversary of the vesting commencement date, May 16, 2020, and at a rate of 2.78% each month thereafter until the option is fully vested."}],"balance_after":9492,"derivative":{"exercise_price":7.22,"expiration_date":"2029-05-16","underlying":"Common Stock","underlying_shares":4182},"source":{"system":"sec-edgar","filing":"0000950170-23-065868","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000095017023065868/ownership.xml","form_type":"4"}},{"id":1731341,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":53594,"kind":"person","name":"Bellon Christine","position":1,"cik":"0001963878","reported_name":"Bellon Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2023-11-22T21:05:11.000Z","date":"2023-11-20","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":31,"value":155000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023."}],"balance_after":82402,"source":{"system":"sec-edgar","filing":"0000950170-23-065868","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000095017023065868/ownership.xml","form_type":"4"}},{"id":1731340,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":53594,"kind":"person","name":"Bellon Christine","position":1,"cik":"0001963878","reported_name":"Bellon Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2023-11-22T21:05:11.000Z","date":"2023-11-20","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":30,"value":150000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023."}],"balance_after":87402,"source":{"system":"sec-edgar","filing":"0000950170-23-065868","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000095017023065868/ownership.xml","form_type":"4"}},{"id":1731339,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":53594,"kind":"person","name":"Bellon Christine","position":1,"cik":"0001963878","reported_name":"Bellon Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2023-11-22T21:05:11.000Z","date":"2023-11-20","kind":"exercise","planned":true,"acquired":true,"shares":5818,"price":7.22,"value":42005.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023."}],"balance_after":92402,"source":{"system":"sec-edgar","filing":"0000950170-23-065868","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000095017023065868/ownership.xml","form_type":"4"}},{"id":1731338,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":53594,"kind":"person","name":"Bellon Christine","position":1,"cik":"0001963878","reported_name":"Bellon Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2023-11-22T21:05:11.000Z","date":"2023-11-20","kind":"exercise","planned":true,"acquired":true,"shares":4182,"price":7.22,"value":30194.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023."}],"balance_after":86584,"source":{"system":"sec-edgar","filing":"0000950170-23-065868","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000095017023065868/ownership.xml","form_type":"4"}},{"id":1765388,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":53594,"kind":"person","name":"Bellon Christine","position":1,"cik":"0001963878","reported_name":"Bellon Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2023-10-04T20:30:09.000Z","date":"2023-10-02","kind":"sale","planned":true,"acquired":false,"shares":388,"price":22.85,"value":8865.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares of common stock were automatically sold in a non-discretionary transaction by the Reporting Person in order to cover tax withholding obligations upon the vesting of certain restricted stock units granted to the Reporting Person under the Beam Therapeutics Inc. 2019 Equity Incentive Plan on September 30, 2021. The sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 19, 2023."}],"balance_after":82402,"source":{"system":"sec-edgar","filing":"0000950170-23-051915","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000095017023051915/ownership.xml","form_type":"4"}},{"id":1925222,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":53594,"kind":"person","name":"Bellon Christine","position":1,"cik":"0001963878","reported_name":"Bellon Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2023-04-06T00:30:15.000Z","date":"2023-04-04","kind":"sale","planned":true,"acquired":false,"shares":1161,"price":29.0931,"value":33777.0891,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares of common stock were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person prior to February 27, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $28.79 to $29.10, inclusive. The Reporting Person undertakes to provide to Beam Therapeutics Inc. (\"BEAM\"), any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":82790,"source":{"system":"sec-edgar","filing":"0000899243-23-010817","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000089924323010817/doc4.xml","form_type":"4"}},{"id":1925221,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":53594,"kind":"person","name":"Bellon Christine","position":1,"cik":"0001963878","reported_name":"Bellon Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2023-04-06T00:30:15.000Z","date":"2023-04-03","kind":"sale","planned":true,"acquired":false,"shares":931,"price":30.31,"value":28218.61,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares of common stock were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person prior to February 27, 2023."}],"balance_after":83951,"source":{"system":"sec-edgar","filing":"0000899243-23-010817","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000089924323010817/doc4.xml","form_type":"4"}},{"id":1934043,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":53594,"kind":"person","name":"Bellon Christine","position":1,"cik":"0001963878","reported_name":"Bellon Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-31T23:51:44.000Z","date":"2023-03-30","kind":"exercise","planned":false,"acquired":false,"shares":2669,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This stock option vests as to 25% on the first anniversary of the vesting commencement date, May 17, 2020, and at a rate of 2.78% each month thereafter until the option is fully vested."}],"balance_after":16736,"derivative":{"exercise_price":7.22,"expiration_date":"2029-05-17","underlying":"Common Stock","underlying_shares":2669},"source":{"system":"sec-edgar","filing":"0000899243-23-010140","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000089924323010140/doc4.xml","form_type":"4"}},{"id":1934042,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":53594,"kind":"person","name":"Bellon Christine","position":1,"cik":"0001963878","reported_name":"Bellon Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-31T23:51:44.000Z","date":"2023-03-30","kind":"exercise","planned":false,"acquired":false,"shares":6272,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option vests as to 25% on the first anniversary of the vesting commencement date, May 16, 2020, and at a rate of 2.78% each month thereafter until the option is fully vested."}],"balance_after":13674,"derivative":{"exercise_price":7.22,"expiration_date":"2029-05-16","underlying":"Common Stock","underlying_shares":6272},"source":{"system":"sec-edgar","filing":"0000899243-23-010140","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000089924323010140/doc4.xml","form_type":"4"}},{"id":1934041,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":53594,"kind":"person","name":"Bellon Christine","position":1,"cik":"0001963878","reported_name":"Bellon Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2023-03-31T23:51:44.000Z","date":"2023-03-31","kind":"grant","planned":false,"acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted to the Reporting Person under the Beam Therapeutics Inc. (\"BEAM\")  2019 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of BEAM's common stock. The RSUs vest in four substantially equal annual installments on each of the first four anniversaries of the date of grant, subject to the Reporting Person's continued service with BEAM through each vesting date."}],"balance_after":84882,"source":{"system":"sec-edgar","filing":"0000899243-23-010140","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000089924323010140/doc4.xml","form_type":"4"}},{"id":1934040,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":53594,"kind":"person","name":"Bellon Christine","position":1,"cik":"0001963878","reported_name":"Bellon Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2023-03-31T23:51:44.000Z","date":"2023-03-30","kind":"exercise","planned":false,"acquired":true,"shares":2669,"price":7.22,"value":19270.18,"ownership":{"direct":true},"balance_after":67382,"source":{"system":"sec-edgar","filing":"0000899243-23-010140","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000089924323010140/doc4.xml","form_type":"4"}},{"id":1934039,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":53594,"kind":"person","name":"Bellon Christine","position":1,"cik":"0001963878","reported_name":"Bellon Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2023-03-31T23:51:44.000Z","date":"2023-03-30","kind":"exercise","planned":false,"acquired":true,"shares":6272,"price":7.22,"value":45283.84,"ownership":{"direct":true},"balance_after":64713,"source":{"system":"sec-edgar","filing":"0000899243-23-010140","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000089924323010140/doc4.xml","form_type":"4"}}]}